Epithelioid hemangioendotheliomas of the liver and lung in children and adolescents

Lung, Respiratory and Thoracic CancerFurther Publications

Response to Osimertinib in a Patient With Non-Small Cell Lung Cancer and Two Uncommon EGFR mutations

healthbook TIMES Oncology Hematology

Astaras C, Bettini A, Betticher D.C

doi: 10.36000/hbT.OH.2020.03.01

Gastrointestinal Cancer

Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection

Eur J Surg Oncol.

Duwe G, Knitter S, Pesthy S, Beierle AS, Bahra M, Schmelzle M, Schmuck RB, Lohneis P, Raschzok N, Öllinger R, Sinn M, Struecker B, Sauer IM, Pratschke J, Andreou A

doi: 10.1016/j.ejso.2017.05.008.

Gastrointestinal CancerGenitourinary CancerLung, Respiratory and Thoracic Cancer

Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report

BMC Cancer.

Casadei Gardini A, Chiadini E, Faloppi L, Marisi G, Delmonte A, Scartozzi M, Loretelli C, Lucchesi A, Oboldi D, Dubini A, Frassineti GL, Ulivi P

doi: 10.1186/s12885-016-2463-2.

Lung, Respiratory and Thoracic Cancer

Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer

N Engl J Med.

Reck M, Rabe KF

doi: 10.1056/NEJMra1703413.

Central Nervous System Tumors

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

Lancet Oncol.

Schwalbe EC, Lindsey JC, Nakjang S, Crosier S, Smith AJ, Hicks D, Rafiee G, Hill RM, Iliasova A, Stone T, Pizer B, Michalski A, Joshi A, Wharton SB, Jacques TS, Bailey S, Williamson D, Clifford SC

doi: 10.1016/S1470-

Lung, Respiratory and Thoracic Cancer

First-line treatment of ALK-positive NSCLC

healthbook TIMES Oncology Hematology

Bouchaab H

doi: 10.36000/hbT.OH.2019.02.008

Lung, Respiratory and Thoracic Cancer

Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer

Lung Cancer.

Paz-Ares LG, Pérol M, Ciuleanu TE, Kowalyszyn RD, Reck M, Lewanski CR, Syrigos K, Arrieta O, Prabhash K, Park K, Pikiel J, Göksel T, Lee P, Zimmermann A, Cuyun Carter G, Alexandris E, Garon EB

Lung, Respiratory and Thoracic Cancer

Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer

JAMA Oncol.

Li B, Cui Y, Diehn M, Li R

doi: 10.1001/

Lung, Respiratory and Thoracic Cancer

Hemifacial Hyperhidrosis in a Patient With an Apical Non-Small Cell Lung Cancer

JAMA Oncol.

Sloan L, Romo CG, Hales RK

doi: 10.1001/jamaoncol.2018.4597.

Related content

Response to Osimertinib in a Patient With Non-Small Cell Lung Cancer and Two Uncommon EGFR mutations

Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection

Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report

Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

First-line treatment of ALK-positive NSCLC

Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer

Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer

Hemifacial Hyperhidrosis in a Patient With an Apical Non-Small Cell Lung Cancer